Drugs / CAR-T
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03258047 | Sep 2017 → Jan 2019 | neoplasm of mature B-cells | First Affiliated Hospital of Zhejiang University | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CAR-T | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03258047 ↗ |
| Modality | Cell therapy | “autologous CAR-T” NCT03258047 ↗ |